BMC Cancer · 2008 · 18 citations · 32 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsDna ReplicationEpigeneticsEpigenetic Alterations In CancerGenomic ImprintingAllelic Replication TimingAsynchronous Replication TimingCytogenetic AberrationsDna In Situ HybridizationEpigenetic Signatures
BACKGROUND: Allelic counterparts of biallelically expressed genes display an epigenetic symmetry normally manifested by synchronous replication, different from genes subjected to monoallelic expression, which normally are characterized by an asynchronous mode of replication (well exemplified by the SNRPN imprinted locus). Malignancy was documented to be associated with gross modifications in the inherent replication-timing coordination between allelic counterparts of imprinted genes as well as of biallelically expressed loci. The cancer-related allelic replication timing aberrations are non-disease specific and appear in peripheral blood cells of cancer patients, including those with solid tumors. As such they offer potential blood markers for non-invasive cancer test. The present study was aimed to gain some insight into the mechanism leading to the replication timing alterations of genes in blood lymphocytes of cancer patients. METHODS: Peripheral blood samples derived from patients with prostate cancer were chosen to represent the cancerous status, and samples taken from patients with no cancer but with benign prostate hyperplasia were used to portray the normal status. Fluorescence In Situ Hybridization (FISH) replication assay, applied to phytohemagglutinin (PHA)-stimulated blood lymphocytes, was used to evaluate the temporal order (either synchronous or asynchronous) of genes in the patients' cells. RESULTS: We demonstrated that: (i) the aberrant epigenetic profile, as delineated by the cancer status, is a reversible modification, evidenced by our ability to restore the normal patterns of replication in three unrelated loci (CEN15, SNRPN and RB1) by introducing an archetypical demethylating agent, 5-azacytidine; (ii) following the rehabilitating effect of demethylation, an imprinted gene (SNRPN) retains its original parental imprint; and (iii) the choice of an allele between early or late replication in the aberrant asynchronous replication, delineated by the cancer status, is not random but is independent of the parental origin. CONCLUSION: The non-disease specific aberrant epigenetic profile displayed in peripheral blood cells of patients with a solid tumour (unlike genetic aberrations) can be reversed, by an epigenetic drug applied in vitro, to the normal. It appears that the cancerous status differentiates between two allelic counterparts in a non-random manner, but independent of the parental origin.
32
Allelic inactivation regulates olfactory receptor gene expression
Andrew Chess, Itamar Simon, Howard Cedar et al. · Cell · 1994 · 1.1K citations
Loss of <i>IGF2</i> Imprinting: A Potential Marker of Colorectal Cancer Risk
Hengmi Cui, Marcia Cruz‐Correa, Francis M. Giardiello et al. · Science · 2003 · 730 citations
Widespread Monoallelic Expression on Human Autosomes
Alexander A. Gimelbrant, John N. Hutchinson, Benjamin R. Thompson et al. · Science · 2007 · 662 citations
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Toshiyuki Sakai, Junya Toguchida, Naoko Ohtani et al. · PubMed · 1991 · 475 citations